Replies to post #161404 on Biotech Values

[DewDiligence]

ABT…has done well, but not as well as ABBV.

True, but it’s been only five months since the separation. ABBV may turn out to be value trap, and ABT is much the better bet for the long haul, IMO.

[DewDiligence]

Update—ABT has now performed considerably better than ABBV since the corporate split on 1/1/13.